191 related articles for article (PubMed ID: 31063500)
1. Radiomic feature stability across 4D respiratory phases and its impact on lung tumor prognosis prediction.
Du Q; Baine M; Bavitz K; McAllister J; Liang X; Yu H; Ryckman J; Yu L; Jiang H; Zhou S; Zhang C; Zheng D
PLoS One; 2019; 14(5):e0216480. PubMed ID: 31063500
[TBL] [Abstract][Full Text] [Related]
2. Spatial-temporal variability of radiomic features and its effect on the classification of lung cancer histology.
Lafata K; Cai J; Wang C; Hong J; Kelsey CR; Yin FF
Phys Med Biol; 2018 Nov; 63(22):225003. PubMed ID: 30272571
[TBL] [Abstract][Full Text] [Related]
3. Associations of Radiomic Data Extracted from Static and Respiratory-Gated CT Scans with Disease Recurrence in Lung Cancer Patients Treated with SBRT.
Huynh E; Coroller TP; Narayan V; Agrawal V; Romano J; Franco I; Parmar C; Hou Y; Mak RH; Aerts HJ
PLoS One; 2017; 12(1):e0169172. PubMed ID: 28046060
[TBL] [Abstract][Full Text] [Related]
4. Identification of optimal mother wavelets in survival prediction of lung cancer patients using wavelet decomposition-based radiomic features.
Soufi M; Arimura H; Nagami N
Med Phys; 2018 Nov; 45(11):5116-5128. PubMed ID: 30230556
[TBL] [Abstract][Full Text] [Related]
5. Interchangeability of radiomic features between [18F]-FDG PET/CT and [18F]-FDG PET/MR.
Vuong D; Tanadini-Lang S; Huellner MW; Veit-Haibach P; Unkelbach J; Andratschke N; Kraft J; Guckenberger M; Bogowicz M
Med Phys; 2019 Apr; 46(4):1677-1685. PubMed ID: 30714158
[TBL] [Abstract][Full Text] [Related]
6. Impact of feature selection methods and subgroup factors on prognostic analysis with CT-based radiomics in non-small cell lung cancer patients.
Sugai Y; Kadoya N; Tanaka S; Tanabe S; Umeda M; Yamamoto T; Takeda K; Dobashi S; Ohashi H; Takeda K; Jingu K
Radiat Oncol; 2021 Apr; 16(1):80. PubMed ID: 33931085
[TBL] [Abstract][Full Text] [Related]
7. Vulnerabilities of radiomic features to respiratory motion on four-dimensional computed tomography-based average intensity projection images: A phantom study.
Adachi T; Nagasawa R; Nakamura M; Kakino R; Mizowaki T
J Appl Clin Med Phys; 2022 Mar; 23(3):e13498. PubMed ID: 35088515
[TBL] [Abstract][Full Text] [Related]
8. Investigation of thoracic four-dimensional CT-based dimension reduction technique for extracting the robust radiomic features.
Tanaka S; Kadoya N; Kajikawa T; Matsuda S; Dobashi S; Takeda K; Jingu K
Phys Med; 2019 Feb; 58():141-148. PubMed ID: 30824145
[TBL] [Abstract][Full Text] [Related]
9. Application and limitation of radiomics approach to prognostic prediction for lung stereotactic body radiotherapy using breath-hold CT images with random survival forest: A multi-institutional study.
Kakino R; Nakamura M; Mitsuyoshi T; Shintani T; Kokubo M; Negoro Y; Fushiki M; Ogura M; Itasaka S; Yamauchi C; Otsu S; Sakamoto T; Sakamoto M; Araki N; Hirashima H; Adachi T; Matsuo Y; Mizowaki T
Med Phys; 2020 Sep; 47(9):4634-4643. PubMed ID: 32645224
[TBL] [Abstract][Full Text] [Related]
10. Optimising use of 4D-CT phase information for radiomics analysis in lung cancer patients treated with stereotactic body radiotherapy.
Davey A; van Herk M; Faivre-Finn C; Brown S; McWilliam A
Phys Med Biol; 2021 May; 66(11):. PubMed ID: 33882470
[No Abstract] [Full Text] [Related]
11. Synergistic impact of motion and acquisition/reconstruction parameters on
Hosseini SA; Shiri I; Hajianfar G; Bahadorzadeh B; Ghafarian P; Zaidi H; Ay MR
Med Phys; 2022 Jun; 49(6):3783-3796. PubMed ID: 35338722
[TBL] [Abstract][Full Text] [Related]
12. Stability and reproducibility of computed tomography radiomic features extracted from peritumoral regions of lung cancer lesions.
Tunali I; Hall LO; Napel S; Cherezov D; Guvenis A; Gillies RJ; Schabath MB
Med Phys; 2019 Nov; 46(11):5075-5085. PubMed ID: 31494946
[TBL] [Abstract][Full Text] [Related]
13. Homology-based radiomic features for prediction of the prognosis of lung cancer based on CT-based radiomics.
Kadoya N; Tanaka S; Kajikawa T; Tanabe S; Abe K; Nakajima Y; Yamamoto T; Takahashi N; Takeda K; Dobashi S; Takeda K; Nakane K; Jingu K
Med Phys; 2020 Jun; 47(5):2197-2205. PubMed ID: 32096876
[TBL] [Abstract][Full Text] [Related]
14. CT-based radiomic analysis of stereotactic body radiation therapy patients with lung cancer.
Huynh E; Coroller TP; Narayan V; Agrawal V; Hou Y; Romano J; Franco I; Mak RH; Aerts HJ
Radiother Oncol; 2016 Aug; 120(2):258-66. PubMed ID: 27296412
[TBL] [Abstract][Full Text] [Related]
15. Discrimination of mediastinal metastatic lymph nodes in NSCLC based on radiomic features in different phases of CT imaging.
Sha X; Gong G; Qiu Q; Duan J; Li D; Yin Y
BMC Med Imaging; 2020 Feb; 20(1):12. PubMed ID: 32024469
[TBL] [Abstract][Full Text] [Related]
16. Distinguishing granulomas from adenocarcinomas by integrating stable and discriminating radiomic features on non-contrast computed tomography scans.
Khorrami M; Bera K; Thawani R; Rajiah P; Gupta A; Fu P; Linden P; Pennell N; Jacono F; Gilkeson RC; Velcheti V; Madabhushi A
Eur J Cancer; 2021 May; 148():146-158. PubMed ID: 33743483
[TBL] [Abstract][Full Text] [Related]
17. Plausibility and redundancy analysis to select FDG-PET textural features in non-small cell lung cancer.
Pfaehler E; Mesotten L; Zhovannik I; Pieplenbosch S; Thomeer M; Vanhove K; Adriaensens P; Boellaard R
Med Phys; 2021 Mar; 48(3):1226-1238. PubMed ID: 33368399
[TBL] [Abstract][Full Text] [Related]
18. 4DCT imaging to assess radiomics feature stability: An investigation for thoracic cancers.
Larue RTHM; Van De Voorde L; van Timmeren JE; Leijenaar RTH; Berbée M; Sosef MN; Schreurs WMJ; van Elmpt W; Lambin P
Radiother Oncol; 2017 Oct; 125(1):147-153. PubMed ID: 28797700
[TBL] [Abstract][Full Text] [Related]
19. Impact of CT convolution kernel on robustness of radiomic features for different lung diseases and tissue types.
Denzler S; Vuong D; Bogowicz M; Pavic M; Frauenfelder T; Thierstein S; Eboulet EI; Maurer B; Schniering J; Gabryś HS; Schmitt-Opitz I; Pless M; Foerster R; Guckenberger M; Tanadini-Lang S
Br J Radiol; 2021 Apr; 94(1120):20200947. PubMed ID: 33544646
[TBL] [Abstract][Full Text] [Related]
20. CT derived radiomic score for predicting the added benefit of adjuvant chemotherapy following surgery in stage I, II resectable non-small cell lung cancer: a retrospective multicohort study for outcome prediction.
Vaidya P; Bera K; Gupta A; Wang X; Corredor G; Fu P; Beig N; Prasanna P; Patil PD; Velu PD; Rajiah P; Gilkeson R; Feldman MD; Choi H; Velcheti V; Madabhushi A
Lancet Digit Health; 2020 Mar; 2(3):e116-e128. PubMed ID: 33334576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
